Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00456196 · ClinicalTrials.gov registry record
Epidemiology of Venous Thromboembolism
A clinical trial of Cancer and COPD, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 5,451
- Enrollment target
- 1
- Study location
NCT00456196: Completed study of Cancer and COPD, sponsored by Brigham and Women's Hospital.
NCT00456196 is a study of Cancer and COPD that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 5,451 participants, above the 3,482-participant average among 615 other Cancer trials with a reported enrollment target (57% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00456196, a study of Cancer and COPD, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 5,451 participants
- Enrollment target
- 1
- Study location
Study Summary
More than 5 years ago the DVT FREE Registry was conceived. Its database consists of 5,451 ultrasound-confirmed DVT patients from 183 institutions. This database is rich in information of critical importance to health care providers. The information contained within the database will be revisited to provide more detailed analyses which will be used for risk factor assessment and for decision-making regarding the implementation of VTE Prophylaxis.
Conditions Studied
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,451 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-06 |
What the finished NCT00456196 record still lists
NCT00456196 is an observational study that tracks outcomes without assigning an intervention. Its 5,451 participants enrollment target places it among the larger protocols in the corpus, above the 3,482-participant average among 615 other Cancer trials with a reported enrollment target (57% higher).
The record links to 5 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00456196 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00456196 about?
NCT00456196 is a clinical study titled "Epidemiology of Venous Thromboembolism". More than 5 years ago the DVT FREE Registry was conceived. Its database consists of 5,451 ultrasound-confirmed DVT patients from 183 institutions. This database is rich in information of critical importance to health care providers. The information contained within the database will be revisited to ...
What is the current status of trial NCT00456196?
This trial is currently completed. The enrollment target is 5,451 participants. The study started on 2006-04. Estimated completion is 2009-06.
What conditions does trial NCT00456196 study?
This clinical trial studies the following conditions: Cancer, COPD, Pulmonary Embolism, Venous Thromboembolism, Deep Vein Thrombosis.
Who is sponsoring clinical trial NCT00456196?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00456196 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00456196's enrollment target sits among peer trials
5,451 40th of 615 higher than 576 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
- NCT05722769 · 5,408 participants · NA
CSTOP Now! Child Sex Trafficking Stops With You
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia